AMIKIN INJECTION 100MG/2ML.
Solution for administration to human beings by injection.
Each vial contains in 2 mL amikacin sulfate equivalent to amikacin activity 100 mg (100,000 international units).
Excipient with known effect: Each vial contains 2.64 mg (0.13 mmol) sodium metabisulfite (E223).
For the full list of excipients, see section 6.1.
Sodium metabisulfite (E223)
Water for injection
Five 2 mL flint glass Type 1 vial with butyl rubber stopper and aluminium seal in a cardboard carton.
Bristol-Myers Squibb Pharmaceuticals Limited, Uxbridge Business Park, Sanderson Road, Uxbridge, Middlesex, UB8 1DH
Date of first authorisation: 26th August 1976
Date of latest renewal: 25th November 2005